36 Medidata Solutions Testimonials

“Something that the Medidata team has helped me solve is giving me a platform for a more efficient trial. It gives us the potential to get it out to patients a year, two years earlier than it might otherwise get out there. That’s huge.”

“The Professional Services group is an absolutely incredible resource. They taught me everything I needed to know so I could do it myself—quickly, easily and correctly… the first time.”

“The partnership with Medidata further underscores TissueTech’s commitment to evidence-based medicine, scientific integrity and continuous research and innovation. Medidata’s unified platform provides us with the technology foundation to scale our clinical research, address the complexity of today’s clinical trials, and build and maintain efficiencies as we continue to grow.”

“We don’t compromise on quality, and we are always innovating and striving for improvement. In Medidata, we have found a technology partner that does the same. Medidata is renowned as one of the best companies in terms of technological solutions for clinical trials.”

"We didn’t go shopping, we knew we wanted to use Medidata and it was a matter of working to find the right study build model to fit our business needs.”

“Having our documentation in a secure, validated environment enables an ease of use for authoring, review, and approval. This allows us to pay attention to other things so we can focus on our product development.”

"Using MS Word documents for visit reporting wasted our CRAs’ time and the reviewer’s time. With Medidata’s cloud-based CTMS, which structures visit report data, CRAs spend 40 percent less time completing a report and site correspondences. We’ve also noticed a reduction in review-to-approval cycle times from 16 days to seven days."

"When compared with traditional cardiovascular trials that engage hundreds or thousands of sites, this technology allowed us to enroll 15,000 participants from 40 centers. We think this infrastructure and approach will facilitate studies that can be direct-to-patient, easier for patients and investigators, and faster to completion."

“Medidata is a valued and trusted partner. We use a range of their solutions which have allowed us to manage various unique and complex study requirements without having to use custom programming. This has ensured consistent and efficient trial execution.”

"Adopting Medidata's machine-learning capabilities for centralized monitoring will not only put us in line with the updated ICH E6 R2 guidelines, but will also allow us to view clinical information at a more holistic level, better prioritize trial resources, and maintain data quality and integrity."

“Everything is there in one place. We can filter by site, we can filter by what’s been dispensed, and it’s really easy for us to track.”

“We’re investing in technology to help us unlock cancer’s secrets, and Medidata’s cloud-based platform provides us with the flexibility and scalability we need to accelerate progress.”

“We chose to partner with Medidata because we recognize that we need an innovative technology partner with deep understanding of CROs and sites and sponsors in order for us to excel in this market. Medidata delivers the right platform, expertise and services that will allow us to be competitive and aggressively scale our full service offerings.”

"Our partnership with Medidata has been very collaborative from a data management perspective in rolling out all the new applications and tools and integrating them with EDC. It’s made data management easier for reviewing the data, drawing out metrics, and building the forms. It’s an easier platform to design and then work with integrating new tools like RTSM or eCOA/ePRO.”

“What Medidata brings to the table, in addition to deep subject matter expertise, is the willingness to keep working until it is right. We can’t do that’ was never a phrase we heard from their Professional Services team.”